These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 21330855

  • 41. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S, Löffler G, Polcher T, Gottschling S, Gortner L.
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: A systematic review.
    Lawson CK, Faine BA, Rech MA, Childs CA, Brown CS, Slocum GW, Acquisto NM, Ray L, EMPHARM-NET Study Group.
    Am J Emerg Med; 2024 Mar; 77():158-163. PubMed ID: 38150986
    [Abstract] [Full Text] [Related]

  • 47. Use of vasopressors in the treatment of cardiac arrest.
    Smith MA.
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):71-5, xi. PubMed ID: 15749405
    [Abstract] [Full Text] [Related]

  • 48. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy B, Buzon J, Kimmoun A.
    Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
    [Abstract] [Full Text] [Related]

  • 49. Continuous therapeutic epinephrine but not norepinephrine prolongs splanchnic IL-6 production in porcine endotoxic shock.
    Bergmann M, Gornikiewicz A, Tamandl D, Exner R, Roth E, Függer R, Götzinger P, Sautner T.
    Shock; 2003 Dec; 20(6):575-81. PubMed ID: 14625484
    [Abstract] [Full Text] [Related]

  • 50. A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure.
    Nandkeolyar S, Ryu R, Mohammad A, Cordero-Caban K, Abramov D, Tran H, Hauschild C, Stoletniy L, Hilliard A, Sakr A.
    J Cardiovasc Pharmacol; 2021 Sep 01; 78(3):336-345. PubMed ID: 34117179
    [Abstract] [Full Text] [Related]

  • 51. Vasopressors and Inotropes in Sepsis.
    Stratton L, Berlin DA, Arbo JE.
    Emerg Med Clin North Am; 2017 Feb 01; 35(1):75-91. PubMed ID: 27908339
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?].
    Schwertz H, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M.
    Dtsch Med Wochenschr; 2004 Sep 10; 129(37):1925-30. PubMed ID: 15372372
    [Abstract] [Full Text] [Related]

  • 57. [Use of vasopressors and inotropics in cardiogenic shock].
    Lemm H, Dietz S, Janusch M, Buerke M.
    Herz; 2017 Feb 10; 42(1):3-10. PubMed ID: 28101622
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.